The effect of positive airway pressure therapy on neurocognitive functions, depression and anxiety in obesity hypoventilation syndrome

Fusun Yildiz (Kocaeli, Turkey), Fusun Yildiz, Serap Argun Baris, Dilek Tuncel, Cigdem Ozerdem, Huseyin Kutlu, Tugba Onyilmaz, Ilknur Basyigit, Hasim Boyaci

Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Session: Treatment options for obstructive sleep apnoea and obesity hypoventilation
Session type: Poster Discussion
Number: 3426
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Fusun Yildiz (Kocaeli, Turkey), Fusun Yildiz, Serap Argun Baris, Dilek Tuncel, Cigdem Ozerdem, Huseyin Kutlu, Tugba Onyilmaz, Ilknur Basyigit, Hasim Boyaci. The effect of positive airway pressure therapy on neurocognitive functions, depression and anxiety in obesity hypoventilation syndrome. Eur Respir J 2016; 48: Suppl. 60, 3426

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cognitive function was improved after continuous positive airway pressure treatment in obstructive sleep apnea syndrome
Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea
Year: 2016


Obesity hypoventilation syndrome and neurocognitive function - impact of positive airway pressure therapy
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018


Evaluation quality of life, anxiety, and depression in patients with obstructive sleep syndrome before and after three and twelve months of continuous positive airway pressure therapy
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Year: 2021


The effect of continuous positive airway pressure on basal metabolism rate in patients with severe obstructive sleep apnea syndrome
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015



Impact of continuous positive airway pressure therapy on atrial electromechanical delay in obesity-hypoventilation syndrome patients
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015

Obesity-hypoventilation syndrome carries an increased risk of death over sleep apnea syndrome
Source: International Congress 2014 – Home noninvasive ventilation: still a "work in progress"?
Year: 2014


Long term effects of compliance with positive airway pressure (PAP) therapy in patients with obesity hypoventilation syndrome (OHS)
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016

Effects of continuous positive airway pressure on arterial stiffness and oxidative stress in patients with obstructive sleep apnoea
Source: International Congress 2016 – New insights into noninvasive ventilation: between the dream and reality
Year: 2016


Effects of 1 year of treatment with nocturnal CPAP in overlap syndrome
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015

Effect of continuous positive airway pressure therapy on metabolic control in patients with morbid obesity and obstructive sleep apnoea
Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing
Year: 2013


Ventilatory management in COPD-associated obstructive sleep apnea syndrome
Source: International Congress 2015 – Novelties in noninvasive ventilation
Year: 2015

Noninvasive ventilatin efficacy for obesity hypoventilation syndrome without severe sleep apnea
Source: International Congress 2016 – Epidemiological aspects of obstructive sleep apnoea
Year: 2016


Factors influencing the level of efficient pressure of continuous positive airway pressure (CPAP) in the treatment of obstructive sleep apnea (OSAS)
Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea
Year: 2016


Efficacy of auto-trilevel positive airway ventilation on patients with both obesity hypoventilation and obstructive sleep apnea syndromes
Source: Annual Congress 2013 –Twist in the tale: treating sleep disordered breathing - new technologies, new techniques
Year: 2013


Blood pressure indices in patients with obstructive sleep apnea and overlap syndrome
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014

Compliance to non-invasive continuous positive airway pressure ventilation in children with obstructive sleep apnoea
Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure
Year: 2015

Effects of continuous positive airway pressure therapy in patients with severe obstructive sleep apnea and endothelial dysfunction on 24-hour blood pressure profile
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015


Factors determining continuous positive airway pressure (CPAP) compliance in obstructive sleep apnea (OSA)
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015

Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea: Effect of continuous positive airway pressure treatment
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013


The role of compliance with positive airway pressure use on blood pressure in patients with obstructive sleep apnea: Is longer use a key-factor?
Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine
Year: 2015